Stocks Overview

LAST PRICE
27.9700
TODAY'S CHANGE (%)
Trending Down-0.4400 (-1.5488%)

Bid / Lots
25.7700/ 4
Ask / Lots
29.3100/ 2
Open / Previous Close
28.4700 / 28.4100
Day Range
Low 27.7800
High 28.8800
52 Week Range
Low 18.8200
High 45.5800
Volume
778,057
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 28.41
Time	Volume	IMVT
09:32 ET	14909	28.72
09:34 ET	800	28.72
09:36 ET	200	28.88
09:38 ET	300	28.88
09:39 ET	2650	28.635
09:41 ET	1739	28.58
09:43 ET	500	28.565
09:45 ET	300	28.21
09:48 ET	311	28.215
09:50 ET	200	28.12
09:52 ET	466	28.11
09:54 ET	1511	28.22
09:56 ET	100	28.265
09:57 ET	300	28.18
09:59 ET	796	28.11
10:01 ET	1400	28.26
10:03 ET	1614	28.325
10:06 ET	400	28.34
10:08 ET	200	28.31
10:10 ET	500	28.26
10:12 ET	900	28.25
10:14 ET	100	28.25
10:15 ET	200	28.24
10:17 ET	1554	28.145
10:19 ET	200	28.1
10:21 ET	400	28.1
10:24 ET	1723	28.11
10:26 ET	2031	28.15
10:28 ET	1100	28.08
10:30 ET	1458	28.105
10:32 ET	270	28.155
10:33 ET	602	28.1
10:35 ET	710	28.16
10:37 ET	200	28.17
10:39 ET	1846	28.2403
10:42 ET	600	28.18
10:44 ET	400	28.16
10:46 ET	3922	28.11
10:48 ET	2600	28.14
10:50 ET	1800	28.165
10:51 ET	1217	28.12
10:53 ET	200	28.11
10:55 ET	442	28.08
10:57 ET	3317	28.06
11:00 ET	2503	27.93
11:02 ET	43941	28.03
11:04 ET	600	28.035
11:06 ET	700	28.04
11:08 ET	1973	27.95
11:09 ET	2000	27.86
11:11 ET	200	27.85
11:13 ET	700	27.84
11:15 ET	500	27.83
11:18 ET	24303	27.865
11:20 ET	600	27.965
11:22 ET	583	27.965
11:24 ET	1942	27.975
11:26 ET	750	28
11:27 ET	8605	27.93
11:29 ET	3087	27.885
11:31 ET	3172	27.89
11:33 ET	1471	27.92
11:36 ET	913	27.98
11:38 ET	500	28.01
11:40 ET	4127	28
11:42 ET	400	28
11:44 ET	4032	27.99
11:45 ET	5517	28
11:47 ET	3065	28.05
11:49 ET	2872	28.08
11:51 ET	1319	28.085
11:54 ET	100	28.06
11:56 ET	801	28.06
11:58 ET	3343	28.12
12:00 ET	5864	28.145
12:02 ET	1353	28.23
12:03 ET	707	28.235
12:05 ET	8848	28.16
12:07 ET	100	28.165
12:09 ET	5003	28.24
12:12 ET	1100	28.22
12:14 ET	400	28.21
12:16 ET	200	28.2
12:18 ET	200	28.2
12:20 ET	1000	28.1
12:21 ET	1300	28.04
12:23 ET	9258	28
12:25 ET	500	27.97
12:27 ET	864	28
12:30 ET	3347	28.065
12:32 ET	1700	27.99
12:34 ET	2815	27.96
12:36 ET	9721	28.01
12:38 ET	1956	28
12:39 ET	3635	28.04
12:43 ET	300	28.03
12:45 ET	400	28.04
12:48 ET	1507	27.985
12:50 ET	1355	27.985
12:52 ET	3958	27.96
12:54 ET	1520	28
12:56 ET	1049	27.95
12:57 ET	3057	28
12:59 ET	2880	28
01:01 ET	300	27.98
01:03 ET	1187	27.94
01:06 ET	100	27.94
01:08 ET	1111	27.94
01:10 ET	2100	27.94
01:12 ET	3118	27.89
01:14 ET	1814	27.88
01:15 ET	1100	27.86
01:17 ET	1732	27.9
01:19 ET	717	27.9
01:21 ET	1300	27.88
01:24 ET	2000	27.86
01:26 ET	2020	27.89
01:28 ET	200	27.89
01:30 ET	900	27.87
01:32 ET	871	27.85
01:33 ET	1700	27.9
01:35 ET	100	27.895
01:37 ET	1500	27.94
01:39 ET	1769	28
01:42 ET	3222	28.02
01:44 ET	200	28.04
01:46 ET	1756	28.03
01:48 ET	457	28.02
01:50 ET	400	28
01:51 ET	100	28
01:53 ET	1300	27.94
01:55 ET	300	27.95
01:57 ET	1524	28.04
02:00 ET	643	28.05
02:02 ET	575	28.05
02:04 ET	600	28.03
02:06 ET	100	28.02
02:08 ET	1300	28.0015
02:09 ET	644	28
02:11 ET	2755	28.03
02:13 ET	7577	27.99
02:15 ET	200	28
02:18 ET	1775	28
02:20 ET	1142	27.97
02:22 ET	1000	27.96
02:24 ET	2519	27.99
02:26 ET	400	27.94
02:27 ET	1118	27.957
02:29 ET	650	27.93
02:31 ET	2655	27.93
02:33 ET	616	27.95
02:36 ET	476	27.96
02:38 ET	417	27.97
02:40 ET	822	27.97
02:42 ET	557	27.96
02:44 ET	918	27.935
02:45 ET	318	27.935
02:47 ET	1993	27.96
02:49 ET	1299	27.97
02:51 ET	878	28
02:54 ET	477	28.01
03:00 ET	473	27.985
03:02 ET	1488	28.025
03:03 ET	1815	28.05
03:05 ET	2701	28.15
03:07 ET	1990	28.1
03:09 ET	3893	28.1
03:12 ET	4187	28.125
03:14 ET	5162	28.055
03:16 ET	3374	28.075
03:18 ET	2186	28.06
03:20 ET	5822	28.15
03:21 ET	1092	28.175
03:23 ET	2165	28.14
03:25 ET	2751	28.11
03:27 ET	11891	28.09
03:30 ET	1187	28.08
03:32 ET	922	28.095
03:34 ET	2457	28.078
03:36 ET	4906	28.03
03:38 ET	1980	27.98
03:39 ET	3857	27.97
03:41 ET	3107	28.005
03:43 ET	2041	27.97
03:45 ET	2469	27.98
03:48 ET	2784	27.97
03:50 ET	2567	27.98
03:52 ET	1895	28
03:54 ET	5145	27.95
03:56 ET	6713	27.895
03:57 ET	13087	27.92
03:59 ET	29171	27.97

Data delayed at least 15 minutes.

No documents available

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesIMVT Immunovant Inc	4.4B	-14.8x	---
United StatesIBRX Immunitybio Inc	4.2B	-5.5x	---
United StatesCRNX Crinetics Pharmaceuticals Inc	4.2B	-14.0x	---
United StatesDYN Dyne Therapeutics Inc	4.1B	-10.5x	---
United StatesRNA Avidity Biosciences Inc	4.8B	-15.3x	---
United StatesNUVL Nuvalent Inc	5.2B	-32.8x	---
As of 2024-07-20

Immunovant, Inc. is a clinical-stage immunology company. The Company is focused on developing treatments for patients with autoimmune diseases. Its product pipeline includes batoclimab and IMVT-1402, both of which are novel, fully human monoclonal antibodies that target the neonatal fragment crystallizable receptor (FcRn). Batoclimab is a subcutaneous injection with dosing. Batoclimab is observed to reduce immunoglobulin G (IgG) antibodies that cause inflammation and disease. Its product candidate, batoclimab, is dosed in small volumes and with a 27-gauge needle. It is developing batoclimab for myasthenia gravis (MG), thyroid eye disease (TED), chronic inflammatory demyelinating polyneuropathy (CIDP) and Graves’ disease (GD). Its lead product candidate IMVT-1402 has also been observed to reduce IgG antibody levels in a Phase I clinical trial conducted in healthy adults. IMVT-1402 is a fully human monoclonal antibody that inhibits FcRn.

Contact Information

Headquarters: 320 West 37Th StreetNEW YORK, NY, United States 10018
Phone: 917-580-3099
Fax: 302-636-5454

Executives

Executive Chairman of the Board: Frank Torti
Chief Executive Office, Director: Peter Salzmann
Chief Financial Officer: Eva Barnett
Chief Technology Officer: Jay Stout
Chief Development Officer: Julia Butchko

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$4.4B
Revenue (TTM)	$0.00
Shares Outstanding	146.1M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.72
EPS	$-1.89
Book Value	$4.24
P/E Ratio	-14.8x
Price/Sales (TTM)	---
Price/Cash Flow (TTM)	---
Operating Margin	---

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Immunovant Inc
NASDAQ:IMVTUnited States

Search Criteria

Charts

Recent News

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar